Related Experiment Video

Updated: Aug 19, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Phosphorylation of mdm2 at serine 269 impairs its interaction with the retinoblastoma protein

Claudia Götz1, Sabine Kartarius, Gertrud Schwär

  • 1Medical Biochemistry and Molecular Biology, University of the Saarland, D-66424 Homburg, Germany.

International Journal of Oncology
|February 11, 2005
PubMed

Insights

Protein kinase CK2 phosphorylation of human mdm2 (hdm2) at serine 269 affects its binding to the retinoblastoma (Rb) protein. This altered interaction influences cell growth in mdm2-deficient cells.

Area of Science:

  • Molecular and Cellular Biology
  • Cancer Research

Background:

  • Protein kinase CK2 is known to phosphorylate human mdm2 (hdm2) at serine residue 269.
  • This phosphorylation site is crucial for mdm2's interaction with various binding partners.

Purpose of the Study:

  • To investigate how CK2-mediated phosphorylation of hdm2 at S269 impacts its interaction with binding partners.
  • To analyze the functional consequences of altered hdm2-Rb interaction on cell growth.

Main Methods:

  • Generation of an S269 phosphospecific antibody for hdm2.
  • Creation of an S269D mutant hdm2 for transfection into mdm2-/- cells.
  • Assessment of retinoblastoma (Rb) protein binding to phosphorylated and unphosphorylated mdm2.

Main Results:

  • The retinoblastoma (Rb) protein exhibited stronger binding to unphosphorylated hdm2 compared to CK2-phosphorylated hdm2.
  • A subpopulation of hdm2 (60 kDa) in human cells was recognized by the S269 phosphospecific antibody.
  • Cells transfected with the S269D mutant hdm2 displayed altered growth characteristics compared to wild-type hdm2-expressing cells.

Conclusions:

  • CK2-dependent phosphorylation of hdm2 at S269 modulates its interaction with Rb.
  • The altered Rb-hdm2 interaction due to S269 phosphorylation may contribute to changes in cell growth behavior.

More Related Videos

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells09:40

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells

Published on: November 2, 2017

Inducible and Reversible Dominant-negative (DN) Protein Inhibition08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...